Skip to main content

. 1968 Aug;43(230):410–414. doi: 10.1136/adc.43.230.410

Evaluation of deficiency of 21-hydroxylation in patients with congenital adrenal hyperplasia.

O M Galal, B T Rudd, N M Drayer

PMCID: PMC2019993 PMID: 4298539

410

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BONGIOVANNI A. M. Adrenogenital syndrome: uncomplicated and hypertensive forms. Pediatrics. 1958 Apr;21(4):661–667. [PubMed] [Google Scholar]
BONGIOVANNI A. M., ROOT A. W. The adrenogenital syndrome. N Engl J Med. 1963 Jun 13;268:1342–contd. doi: 10.1056/NEJM196306132682406. [DOI] [PubMed] [Google Scholar]
JACOBS D. R., VAN DER POLL J., GABRILOVE J. L., SOFFER L. J. 17alpha-Hydroxyprogesterone--a salt-losing steroid: relation to congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1961 Aug;21:909–922. doi: 10.1210/jcem-21-8-909. [DOI] [PubMed] [Google Scholar]
KOWARSKI A., FINKELSTEIN J. W., SPAULDING J. S., HOLMAN G. H., MIGEON C. J. ALDOSTERONE SECRETION RATE IN CONGENITAL ADRENAL HYPERPLASIA. A DISCUSSION OF THE THEORIES ON THE PATHOGENESIS OF THE SALT-LOSING FORM OF THE SYNDROME. J Clin Invest. 1965 Sep;44:1505–1513. doi: 10.1172/JCI105257. [DOI] [PMC free article] [PubMed] [Google Scholar]
SILBER R. H., PORTER C. C. The determination of 17,21-dihydroxy-20-ketosteroids in urine and plasma. J Biol Chem. 1954 Oct;210(2):923–932. [PubMed] [Google Scholar]
ULICK S., GAUTIER E., VETTER K. K., MARKELLO J. R., YAFFE S., LOWE C. U. AN ALDOSTERONE BIOSYNTHETIC DEFECT IN A SALT-LOSING DISORDER. J Clin Endocrinol Metab. 1964 Jul;24:669–672. doi: 10.1210/jcem-24-7-669. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES